• The hospital’s neonatal intensive care unit department to incorporate the Comprehensive Unit-Based Safety Program (CUSP), originally developed by Johns Hopkins Hospital in Maryland, USA

Abu Dhabi, UAE – The neonatal intensive care unit (NICU) at Danat Al Emarat Hospital for Women & Children, part of the M42 group, has implemented the Comprehensive Unit-Based Safety Program (CUSP), an internationally-recognized safety program. Originally developed by the globally renowned Johns Hopkins Hospital, CUSP focuses on enhancing safety across all aspects of operations including patient care through improved team communication and shared learnings. This further cements the hospital’s status as a leader in neonatal care in the UAE.

CUSP addresses risks such as infections and medication errors, involving multidisciplinary teams, executive involvement and regular safety reviews to drive continuous improvement. Educational and teambuilding sessions further promote respect, collaboration and ongoing development within the NICU team.

Dr. Summia Zaher, Chief Executive Officer at Danat Al Emarat Hospital for Women & Children, said: “As a leader in neonatal care, Danat Al Emarat Hospital for Women & Children is aware of how challenging it can be for families with babies in a neonatal intensive care unit. The recent implementation of the internationally recognized Comprehensive Unit-Based Safety Program (CUSP) is part of the broader culture of safety that we foster across our patient services. This initiative reflects our ongoing commitment to excellence in neonatal healthcare and highlights our dedication to improving outcomes for all our patients.”

Dr. Vineet Gupta, Consultant Neonatologist at Danat Al Emarat Hospital for Women & Children, added: “Our neonatal intensive care unit is among the largest and most advanced in Abu Dhabi, caring for over 100 premature babies each month. The introduction of the Comprehensive Unit-Based Safety Program (CUSP) underscores our commitment to delivering the highest level of care to babies and their families.”

Another CUSP initiative focuses on Antibiotic Stewardship, analyzing infection risks and antibiotic sensitivity patterns in newborns across the UAE using data from the past seven years. The findings will help the hospital administer antibiotics more carefully, addressing newborns’ vulnerability to infections and minimizing the risks associated with antibiotic resistance.

Another aligned effort is the Neonatal Departmental Clinical Governance Pathway, a risk matrix designed to assess incidents reports in the NICU. This objective scoring system identifies potential harm to newborns and highlights high-risk areas to focus on. Introduced in early October, it represents an important step toward improving safety and care quality for infants.

To learn more about Danat Al Emarat Hospital for Women & Children or to book an appointment, please call 800 96626 or visit https://danatalemarat.ae.

-Ends-

About Danat Al Emarat Hospital

Danat Al Emarat, part of the M42 group, is a world-class specialty women and children’s hospital located in Abu Dhabi, United Arab Emirates.

The five-story hospital, accredited as a clinical research center by the Department of Health – Abu Dhabi, covers an area of 58,000 square meters, with 225 beds. The hospital offers a comprehensive range of inpatient and outpatient medical and surgical services including Neonatology & Pediatrics, Surgery, Obstetrics & Gynecology, Internal Medicine, Women’s Diagnostics & Breast Imaging, and others, all of which are equipped with the latest technology and led by highly qualified clinicians to provide unmatched patient and family-centered care.

Our medical team is hand-picked from the international and local market specializing in numerous sub-specialties. Our 130+ consultants and primary care physicians work closely together to ensure the entire needs of women and children are addressed in a single convenient location and to the highest standards.

About M42

M42 is a first-of-its-kind, global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative solutions that are solving the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalized, precise, and preventative health solutions to impactfully disrupt the global health landscape.

M42 has over 20,000 employees and more than 450 facilities in 26 countries. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 combines leading health technologies with state-of-the-art healthcare facilities to deliver world-class health solutions, services and care.

The M42 group includes Diaverum, Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre and Moorfields Eye Hospital Abu Dhabi, among others.

For more information, please contact:
Maroun Farah
Senior Media Relations Manager
Weber Shandwick
e-mail: mfarah@webershandwick.com